Lot-to-lot variation in anti-hepatitis C signal-to-cut-off ratio

Clinical Chemistry

Volumn 50, Issue 5, 2004, Pages 958-960

  Dufour, D Robert ^a,b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS ANTIBODY; VIRUS RNA;

ARTICLE; CHEMOLUMINESCENCE; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; INTERMETHOD COMPARISON; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCREENING; STATISTICAL ANALYSIS;

CHEMILUMINESCENT MEASUREMENTS; DATABASES, FACTUAL; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOENZYME TECHNIQUES; LABORATORY TECHNIQUES AND PROCEDURES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RNA, VIRAL; VIROLOGY;

HEPATITIS C VIRUS;

EID: 2142696591     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.031039     Document Type: Article

References (10)

1. Alter M, Kruszon-Moran D, Nainan O, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
2. Kim W. The burden of hepatitis C in the United States. Hepatology 2002;36:530-4.
3. Roselle G, Danko L, Kralovic S, Simbartl L, Kizer K. National Hepatitis C Surveillance Day in the Veterans Health Administration of the Department of Veterans Affairs. Mil Med 2002;167:756-9.
4. Cheung R. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol 2000;95:740-7.
5. Briggs M, Baker C, Hall R, Gaziano JM, Gagnon D, Bzowej N, et al. Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center. Hepatology 2001;34:1200-5.
6. Davis G, Albright J, Cook S, Rosenberg D. Projecting future complications of chronic hepatitis C in the United States. Liver Transplant 2003;9:331-8.
7. Pawlotsky J. Use and interpretation of virological tests for hepatitis C. Hepatology 2002;36:S65-73.
8. Dufour D, Talastas M, Feranndez M, Harris B. Chemiluminescence assay improves specificity of hepatitis C antibody detection. Clin Chem 2003;49: 940-4.
9. Dufour D, Talastas M, Fernandez M, Harris B, Strader D, Seeff L. Low positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. Clin Chem 2003;49:479-86.
10. Alter M, Kuhnert W, Finelli L. Guidelines for laboratory testing and results reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003;52:1-3. 15, quiz CE1-4.